mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.01 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
0.01 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.01 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.02 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.02 |